Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The GABA-A receptor α6β2γ2 subtype is a heteropentameric ligand-gated ion channel that mediates inhibitory neurotransmission in the central nervous system [1, 8]. It is primarily expressed in the granule cells of the cerebellum, where it plays a specialized role in regulating motor coordination and sensory input [2, 15]. Unlike many other GABA-A receptor subtypes, the α6-containing variant is "diazepam-insensitive" due to a specific arginine residue in the α6 subunit that prevents the binding of classical benzodiazepines [4, 15]. This receptor subtype contributes significantly to tonic inhibition, providing a continuous inhibitory tone that modulates neuronal excitability [1, 12]. Dysregulation of α6β2γ2 receptors has been linked to conditions such as tinnitus, essential tremor, and neuropsychiatric disorders like schizophrenia [1, 9]. Pharmacological targeting of this subtype with selective modulators like hispidulin or DK-I-56-1 is being explored for therapeutic potential in treating cerebellar-related motor deficits and sensory hypersensitivity [1, 2].
Positive allosteric modulation, Negative allosteric modulation, Agonism [1, 2, 4]
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gamma-aminobutyric acid type A receptor alpha-6 beta-2 gamma-2 subtype (GABA-A receptor α6β2γ2).